Continuous retrograde blood cardioplegia is associated with lower hospital mortality after heart valve surgery

Area of Science:

• Cardiology
• Cardiac Surgery
• Cardiothoracic Surgery

Background:

• Previous studies on myocardial preservation comparing blood and crystalloid cardioplegia focused on coronary bypass surgery without demonstrating mortality differences.
• Limited research exists on the impact of cardioplegia techniques on hospital mortality in cardiac valve surgery patients.

Purpose of the Study:

• To investigate the influence of cardioplegia techniques on hospital mortality in patients undergoing cardiac valve surgery.
• To compare the outcomes of single-shot antegrade cold crystalloid cardioplegia versus continuous retrograde cold blood cardioplegia in this patient population.

Main Methods:

• A retrospective analysis of 1098 consecutive cardiac valve surgery patients was conducted.
• Multivariate logistic regression with propensity score balancing was used to evaluate hospital mortality.
• Patients were divided into two cohorts: one receiving crystalloid cardioplegia and the other receiving blood cardioplegia.

Main Results:

• Continuous retrograde blood cardioplegia was associated with significantly lower hospital mortality (P =.020).
• The odds ratio for in-hospital death with blood cardioplegia was 0.44 (95% CI, 0.22-0.88).
• Independent predictors of mortality included age, NYHA functional class, cardiopulmonary bypass time, reoperation, endocarditis, and renal failure.

Conclusions:

• Continuous retrograde blood cardioplegia is linked to reduced hospital mortality in cardiac valve operations.
• This technique may offer improved myocardial protection during valve surgery.
• Further research may explore the mechanisms behind this observed mortality benefit.